Clovis says it needs money after reverse split voted down; CinCor touts PhII data for hypertension drug
Clovis Oncology needs a serious leg up after posting a $71.3 million net loss in Q2.
According to the company’s Q2 report, based on its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
